Related references
Note: Only part of the references are listed.Roles of p38 MAPK and JNK in TGF-β1-induced Human Alveolar Epithelial to Mesenchymal Transition
Hai-hua Chen et al.
ARCHIVES OF MEDICAL RESEARCH (2013)
Anti-inflammatory effect and selectivity profile of AS1940477, a novel and potent p38 mitogen-activated protein kinase inhibitor
Masaomi Terajima et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2013)
Release of Severe Acute Respiratory Syndrome Coronavirus Nuclear Import Block Enhances Host Transcription in Human Lung Cells
Amy C. Sims et al.
JOURNAL OF VIROLOGY (2013)
Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
V. Stalin Raj et al.
NATURE (2013)
Development of PI3K inhibitors: lessons learned from early clinical trials
Jordi Rodon et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2013)
Human Coronavirus EMC Is Not the Same as Severe Acute Respiratory Syndrome Coronavirus
Stanley Perlman et al.
MBIO (2013)
Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential
Eveline Kindler et al.
MBIO (2013)
The newly emerged SARS-Like coronavirus HCoV-EMC also has an Achilles' heel: current effective inhibitor targeting a 3C-like protease
Zhilin Ren et al.
PROTEIN & CELL (2013)
Emerging Role of Ubiquitination in Antiviral RIG-I Signaling
Jonathan Maelfait et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Into the Eye of the Cytokine Storm
Jennifer R. Tisoncik et al.
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS (2012)
Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
Ali Moh Zaki et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Regulation of epithelial immunity by IL-17 family cytokines
Rajita Pappu et al.
TRENDS IN IMMUNOLOGY (2012)
Replication of human coronaviruses SARS-CoV, HCoV-NL63 and HCoV-229E is inhibited by the drug FK506
Javier Carbajo-Lozoya et al.
VIRUS RESEARCH (2012)
Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines
Marcel A. Mueller et al.
MBIO (2012)
Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans
Sander van Boheemen et al.
MBIO (2012)
Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections
Stephan Ludwig
BIOLOGICAL CHEMISTRY (2011)
IL-17 Boosts Proinflammatory Outcome of Antiviral Response in Human Cells
Grigory Ryzhakov et al.
JOURNAL OF IMMUNOLOGY (2011)
Design and Synthesis of Inhaled p38 Inhibitors for the Treatment of Chronic Obstructive Pulmonary Disease
David S. Millan et al.
JOURNAL OF MEDICINAL CHEMISTRY (2011)
Evaluation of the Calu-3 cell line as a model of in vitro respiratory syncytial virus infection
Jennifer L. Harcourt et al.
JOURNAL OF VIROLOGICAL METHODS (2011)
Host Regulatory Network Response to Infection with Highly Pathogenic H5N1 Avian Influenza Virus
Chengjun Li et al.
JOURNAL OF VIROLOGY (2011)
Discovery and Preclinical Validation of Drug Indications Using Compendia of Public Gene Expression Data
Marina Sirota et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
The SARS-Coronavirus-Host Interactome: Identification of Cyclophilins as Target for Pan-Coronavirus Inhibitors
Susanne Pfefferle et al.
PLOS PATHOGENS (2011)
Novel p38 MAPK inhibitor ML3403 has potent anti-inflammatory activity in airway smooth muscle
Lenka Munoz et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2010)
Dynamic Innate Immune Responses of Human Bronchial Epithelial Cells to Severe Acute Respiratory Syndrome-Associated Coronavirus Infection
Tomoki Yoshikawa et al.
PLOS ONE (2010)
Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals
Laurence Josset et al.
PLOS ONE (2010)
BioMart - biological queries made easy
Damian Smedley et al.
BMC GENOMICS (2009)
Novel HIV-1 therapeutics through targeting altered host cell pathways
William Coley et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2009)
Critical Role of IL-17RA in Immunopathology of Influenza Infection
Christopher R. Crowe et al.
JOURNAL OF IMMUNOLOGY (2009)
Activation of the PI3K/Akt Pathway Early during Vaccinia and Cowpox Virus Infections Is Required for both Host Survival and Viral Replication
Jamaria A. P. Soares et al.
JOURNAL OF VIROLOGY (2009)
MHC class I antigen presentation: learning from viral evasion strategies
Ted H. Hansen et al.
NATURE REVIEWS IMMUNOLOGY (2009)
Effect of the phosphatidylinositol 3-kinase/Akt pathway on influenza A virus propagation
Yeun-Kyung Shin et al.
JOURNAL OF GENERAL VIROLOGY (2007)
Innovation - The Connectivity Map: a new tool for biomedical research
Justin Lamb
NATURE REVIEWS CANCER (2007)
Mitogen activated protein kinase inhibitors: where are we now and where are we going?
S. E. Sweeney et al.
ANNALS OF THE RHEUMATIC DISEASES (2006)
SARS: Systematic review of treatment effects
Lauren J. Stockman et al.
PLOS MEDICINE (2006)
The respiratory syncytial virus small hydrophobic protein is phosphorylated via a mitogen-activated protein kinase p38-dependent tyrosine kinase activity during virus infection
HWM Rixon et al.
JOURNAL OF GENERAL VIROLOGY (2005)
Current concepts: The severe acute respiratory syndrome
JSM Peiris et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Reverse genetics with a full-length infectious cDNA of severe acute respiratory syndrome coronavirus
B Yount et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
The MHC class I antigen presentation pathway: strategies for viral immune evasion
EW Hewitt
IMMUNOLOGY (2003)
Identification of a novel coronavirus in patients with severe acute respiratory syndrome
C Drosten et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Viral inhibition of MHC class II antigen presentation
NR Hegde et al.
TRENDS IN IMMUNOLOGY (2003)
Effect of p38 mitogen-activated protein kinase on the replication of encephalomyocarditis virus
K Hirasawa et al.
JOURNAL OF VIROLOGY (2003)
Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method
KJ Livak et al.
METHODS (2001)
Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: Inhibition of PI3-K activity inhibits viral replication and virus-induced signaling
RA Johnson et al.
JOURNAL OF VIROLOGY (2001)